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a  b  s  t  r  a  c  t
The  transmission  of  malaria  parasites  depends  on the  presence  of  sexual  stages  (gametocytes)  in  the
blood,  making  the  ratio  and densities  of female  and  male  gametocytes  important  determinants  of  parasite
ﬁtness.  This  manuscript  describes  the  development  of  reverse  transcriptase  quantitative  PCR (RT-qPCR)
assays  to separately  quantify  mature  female  and  male  gametocytes  of the human  malaria  parasite  Plasmo-
dium  falciparum,  and  reveals  that  Pfs25 mRNA  is  expressed  only  in female  gametocytes.  The  female  (Pfs25)
and  male  (Pfs230p)  gametocyte  speciﬁc  RT-qPCR  assays  have  lower  detection  limits  of 0.3  female  and 1.8
male gametocytes  per  microlitre  of  blood,  respectively,  making  them  more  sensitive  than  microscopy.
Accurate  quantiﬁcation  of  the  ratio  and  densities  of  female  and  male  gametocytes  will increase  under-
standing  of  P.  falciparum  transmission  and  improve  the  evaluation  of  transmission  blocking  interventions.
© 2015  The  Authors.  Published  by  Elsevier  B.V.  This  is  an open  access  article  under  the  CC  BY  license
(http://creativecommons.org/licenses/by/4.0/).
For malaria (Plasmodium) parasites, transmission between ver-
tebrate hosts requires a mosquito vector. Throughout infections in
the vertebrate host, Plasmodium produces female and male sexual
stages (gametocytes). Upon ingestion by a blood-feeding mosquito,
gametocytes differentiate into gametes, mate, and after several
developmental transitions, the progeny are able to infect another
vertebrate host. The densities of female and male gametocytes in
the blood and the sex ratio (proportion of gametocytes that are
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male) inﬂuence infectivity to mosquitoes, and so, onwards trans-
mission to new hosts [1–3].
Techniques to determine the sex of P. falciparum gametocytes
are laborious. They include microscopical examination of Giemsa-
stained thin blood smears and immunoﬂuorescence assays using
antibodies recognising female- and/or male-speciﬁc antigens [4].
Furthermore, the sensitivity of these methods is low: transmission
to mosquitoes readily occurs at densities below the microscopic
detection limit of 8–16 gametocytes/l  [3,5]. This makes it very
difﬁcult to obtain accurate estimates of sex-speciﬁc gametocyte
densities, and sex ratios, from as many as 50% of infections capable
of transmitting to mosquitoes [3] because in some cases as few as 10
gametocytes are sexed [6]. However, separately following the den-
sities of female and male gametocytes during natural infections is
necessary to understand how their dynamics and sex ratios inﬂu-
ence disease transmission and to evaluate transmission blocking
interventions [2,7].
To facilitate the study of P. falciparum female and male game-
tocyte dynamics and gametocyte sex ratios, high-throughput,
sensitive molecular methods for the quantiﬁcation of mature
http://dx.doi.org/10.1016/j.molbiopara.2015.03.006
0166-6851/© 2015 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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Table 1
P. falciparum female (Pfs25) or male (Pfs230p) gametocyte-speciﬁc RT-qPCRs.
Sequences for forward primers (FW), reverse primers (RV) and TaqMan probe (P) are
shown with their location, based on genbank accession numbers AE014185.2 and
AE001362.1 for the Pfs25 (PF3D7 1031000) and Pfs230p (PF3D7 0208900) assays.
Name Sequence Location
Pfs25-FW: CCATGTGGAGATTTTTCCAAATGTA 1253852–1253828
Pfs25-RV: catttaccgttaccacaagttaCATTC 1253710–1253736
Pfs25-P1: 6FAM-ccgtttcatacgcttgtaa-MGB 1253809–1253791
Pfs230p-FW3: CCCAACTAATCGAAGGGATGAA 363440–363461
Pfs230p-RV4: AGTACGTTTAGGAGCATTTTTTGGTAA 363635–363609
PCR conditions
Pfs25 assay: 900 nM of forward and reverse primers, 250 nM probe (MGB-TaqMan
probes, Life Technologies), 500 nM ROX reference dye and 1x PCR reaction buffer
3  mM MgCl2, 0.4 mM dNTPs, 1 unit taq (FastStart Taq dNTPack, Roche); Pfs230p
assay: 900 nM of forward and reverse primers, 1x GoTaq® qPCR mastermix includ-
ing  BRYT Green® (Promega). Both assays can be run simultaneously within the same
PCR plate since they use the same PCR programme (95 ◦C 10 min; 45 cycles of: 95 ◦C
15 s, 60 ◦C 1 min) and despite different detection chemistries both assays require
detection in the FAM channel). For details on sample processing see Supplementary
data, section 3).
female and male gametocytes were developed. The female-speciﬁc
assay quantiﬁes mRNA of the gene encoding Pfs25 (PF3D7 1031000).
Pfs25 is expressed in late stage gametocytes, shows limited poly-
morphism and is currently used to quantify gametocytes from ﬁeld
isolates [3,8].
The sex-speciﬁcity of Pfs25 mRNA expression is tested in this
manuscript, and conﬁrmed to be female-speciﬁc, like mRNA of its
orthologue in the rodent malaria P. berghei (Pbs21) [9,10].
Only a few P. falciparum male-speciﬁc proteins have been
described. The most well-known are alpha-tubulin II and the Pfs230
paralogue, Pfs230p [11,12]. Low levels of -tubulin II protein have
been demonstrated in asexual blood stages and early stage female
gametocytes [12]. Therefore, the male-speciﬁc assay quantiﬁes
Pfs230p (PF3D7 0208900) mRNA [11], and its speciﬁc expression in
late stage male gametocytes is veriﬁed. The design, optimisation,
and validation (including the assessment of speciﬁcity and sensi-
tivity) of assays to quantify female or male P. falciparum mature
gametocytes, are presented below.
Primers and probe (Table 1) for the Pfs25 and Pfs230p assays
are P. falciparum speciﬁc (BLAST). No signiﬁcant single nucleotide
polymorphisms were detected in the Pfs25 and Pfs230p primer and
probe regions among almost 2000 P. falciparum samples collected
from all over the world, (The Pf3K Project (2014): pilot data release
2. www.malariagen.net/data/pf3k-2) [13]. Therefore, the primers
and probe are suitable for use on ﬁeld samples that potentially
contain multiple parasite genotypes. To provide large amounts of
material from the target genes for assay optimisation and calibra-
tion, independent of the need to repeatedly culture P. falciparum
parasites, constructs were made to produce DNA, RNA and cDNA
in vitro (Supplementary data, section 1). Because the target genes
have single exons, DNA sequences of the target regions (in vitro-
produced DNA: ivDNA) and cDNA are identical, so ivDNA was used
to optimise assay conditions (Table 1). PCR efﬁciencies for the Pfs25
and Pfs230p qPCRs were 93.6% with a standard error (se) of 1.5%, and
98.5 (se 2.4%), respectively. Ampliﬁcation was not observed in the
no-template controls, and the lower limit of detection was  similar
at 9 and 2 molecules/25 l reaction for the Pfs25 and Pfs230p qPCRs,
respectively (Fig. 1). The concentration of Pfs25 and Pfs230p ivDNA
was highly correlated to PCR quantiﬁcation cycles (Cq; adjusted
r2 = 0.98, p < 0.001 for both assays) and the small standard errors
indicate high repeatability between replicates (Fig. 1; for details
on statistical analysis see Supplementary data, section 2). In sum-
mary, the assays are sensitive and quantify their respective ivDNA
accurately.
Next, the Pfs25 and Pfs230p assays were assessed for species-
speciﬁcity. The Pfs25 and Pfs230p assays do not amplify nucleic
acids from uninfected human blood samples that were collected
from volunteer donors (n = 10, with written informed consent).
Orthologues for the Pfs25 and Pfs230p genes are present in P. vivax,
P. knowlesi, and in the rodent malaria species P. berghei and P.
chabaudi (PlasmoDB.org). Sequence similarity between the P. fal-
ciparum sequences and the different orthologues is comparable
(44–47% for Pfs25, 41–42% for Pfs230p). Therefore, and given the
difﬁculty in obtaining samples for single-species infections of P.
knowlesi or P. vivax, DNA from P. chabaudi (CW) and P. berghei
(ANKA) (from experiments carried out in accordance with the UK
Animals Scientiﬁc Procedures Act 1986) was used to empirically
test P. falciparum species-speciﬁcity of the Pfs25 and Pfs230p qPCR
assays. No amplicons were detected, conﬁrming the in silico analy-
sis.
For the assessment of stage- and sex-speciﬁcity and to deter-
mine sensitivity of the assays, a variety of P. falciparum samples
were used. These samples include: (1) “Asexual stages”: sorbitol-
synchronised asexual ring stage parasites (clone 3D7), freed of
gametocytes through magnetic separation [14,15]; (2) “Mixed sex
gametocytes” free of asexual stages after treatment with N-acetyl
glucosamine [15], including (a) sample 3D7-1: gametocytes of
clone 3D7 at development stage IV, with a sex ratio (proportion of
gametocytes that are males) of 0.05 as determined by morpholog-
ical examination of Giemsa stained thin ﬁlms; (b) sample 3D7-2:
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Fig. 1. The Pfs25 TaqMan and Pfs230p BRYT Green® qPCRs are sensitive and accurate for the quantiﬁcation of their respective DNA target sequences (ivDNA, Supplementary
data,  section 1). Average Cq values with standard errors are presented for the quantiﬁcation of 13 and 4 dilution series of respectively Pfs25 ivDNA and Pfs230p ivDNA.
Regression equations are Pfs25: Cq value = −3.49 × 10 log Pfs25 ivDNA/PCR + 41.39, r2 = 0.98, p < 0.001; Pfs230p: Cq value = −3.36 × 10 log Pfs230p ivDNA/PCR + 31.95, r2 = 0.98,
p  < 0.001.
P. Schneider et al. / Molecular & Biochemical Parasitology 199 (2015) 29–33 31
25
30
35
40
45
10-2 10-1 100 10 1 10 2 10 3
C
q 
va
lu
e
female gametocytes/PCR reaction
purified females
3D7-1
3D7-2
females in purified males
104
20
25
30
35
10-1 100 10 1
C
q 
va
lu
e
male gametocytes/PCR reaction
purifi ed males
NF54
3D7-1
3D7-2
102
Fig. 2. Gametocyte quantiﬁcation by sex-speciﬁc RT-qPCR. The Pfs25 TaqMan (2A) and Pfs230p BRYT Green® (2B) RT-qPCRs are sensitive and accurate for the quantiﬁcation
of  respectively female and male gametocytes. To enable direct comparison of various sample processing methods (see Supplementary data, section 3) average Cq values
with  standard errors are presented for the number of female (2A) or male (2B) gametocytes/PCR reaction. Pfs25 RT-qPCR: data originate from cDNA of 2 RNA extractions
each  for “Puriﬁed females”, “Puriﬁed males”, “Mixed sex gametocytes” 3D7-1 and 3D7-2 respectively, with each sample measured in 2–7 replicates. Regression equation:
Cq  value = −3.62 × 10 log female gametocytes/PCR + 41.18, r2 = 0.97, p < 0.001 (2A); Pfs230p RT-qPCR: data originate from cDNA of 1, 3, 2 and 3 RNA extractions for “Puriﬁed
females”, “Mixed sex gametocytes” 3D7-1, 3D7-2 and NF54 respectively, with each sample measured in 2–8 replicates. Regression equation: Cq value = −3.53 × 10 log male
gametocytes/PCR + 29.78, r2 = 0.91, p < 0.001 (2B).
3D7 stage IV gametocytes depleted of uninfected red blood cells
by magnetic puriﬁcation [14] with a sex ratio of 0.05 determined
by morphological examination of Giemsa stained thin ﬁlms; (c)
sample NF54: stage IV-V gametocytes of isolate NF54. NF54 para-
sites cultured using the methods as described in [15] consistently
have a sex ratio of 0.2 as determined by morphological examina-
tion of Giemsa stained thin ﬁlms; (3) “Puriﬁed females”: stage IV-V
gametocytes of line p47GFP (derived from NF54) that expresses
green ﬂuorescent protein speciﬁcally in female gametocytes, puri-
ﬁed using ﬂow cytometry, free from asexual stages and containing
98% females (assessed by re-sorting aliquots by ﬂow cytometry
[16]); and (4) “Puriﬁed males”: stage IV-V gametocytes of line Dyn-
GFP (derived from NF54) that expresses green ﬂuorescent protein
speciﬁcally in male gametocytes, puriﬁed using ﬂow cytometry,
free of asexual stages and containing >98% males (assessed by ﬂow
cytometry) [16]. Samples were stored in RNA-preserving reagents
(for details on sample processing see Supplementary data, section
3) and stored at −70 ◦C. RNA from all samples were extracted on a
semi-automatic MagMAXTM Express Particle Processor (Life Tech-
nologies) using the MagMAXTM-96 total RNA isolation kit according
to manufacturer’s protocol, with the exception of RNA from the
“Mixed sex gametocytes NF54” sample, which was processed in
a different laboratory (Supplementary data, section 3) and was
extracted using the MagNAPure system at protocol HS500 and the
MagNAPure LC Total Nucleic Acid Kit–High Performance. All sam-
ples were DNAse I treated (RQ1, Promega) and conﬁrmed to be
DNA free by 18S qPCR [17] before cDNA was synthesised by reverse
transcriptase PCR (High capacity cDNA Reverse Transcription Kit,
Life Technologies). The female-speciﬁc Pfs25 qPCR followed by the
male-speciﬁc Pfs230p qPCR are presented the following paragraphs.
First, to test whether Pfs25 mRNA expression is female
gametocyte-speciﬁc, like mRNA of its orthologue in the rodent
malaria P. berghei (Pbs21) [9,10], qPCR was performed using cDNA
from “Asexual stages” (8.9 × 105 parasites/l  blood) and the “Puri-
ﬁed males” (6.7 × 103 gametocytes/l  blood, <2% females). No
amplicons were obtained with samples from “Asexual stages”,
conﬁrming gametocyte-speciﬁcity. However, low levels of Pfs25
amplicons were detected from the “Puriﬁed males”. The expression
of Pfs25 mRNA for each gametocyte from the “Puriﬁed males” was
signiﬁcantly lower than in the “Puriﬁed females”, and “Mixed sex
gametocytes” samples 3D7-1 and 3D7-2 (F3,178 = 253.11, p < 0.001).
Pfs25 mRNA expression was 274-fold higher in the “Puriﬁed
females”, which is consistent with the “Puriﬁed males” (purity
expected to be >98% males) containing a 0.36% contamination
of female gametocytes. When the proportion of female gameto-
cytes in each sample (0.36%, 95% and 98% for the “Puriﬁed males”,
“Puriﬁed females”, “Mixed sex gametocytes” 3D7-1 and 3D7-2,
respectively) is taken into account, there are no signiﬁcant dif-
ferences in Pfs25 mRNA expression per female gametocyte across
these sex ratios (F3,178 = 2.63, p = 0.052; Fig. 2A). Extremely low
expression of Pfs25 mRNA in male gametocytes cannot be ruled out,
but even in this case, the 274-fold lower mRNA expression in male
versus female gametocytes will not signiﬁcantly reduce the ability
of the Pfs25 assay to accurately quantify female gametocytes. There-
fore, the Pfs25 RT-qPCR, and the Pfs25 QT-NASBA currently used for
ﬁeld surveys [3], can be considered to quantify female gametocytes
only.
The Pfs25 qPCR assay’s sensitivity, PCR efﬁciency, and accuracy
of quantiﬁcation were assessed using 4 samples: “Mixed sex game-
tocytes” samples (clone 3D7, 2 samples each with 95% females;
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spanning cDNA densities equivalent to 0.17–9.37 × 103 (3D7-1)
and 0.34–5.86 × 103 (3D7-2) female gametocytes/l  blood); the
“Puriﬁed females” (line p47GFP, 98% females; spanning cDNA den-
sities equivalent to 0.33–1.68 × 104 female gametocytes/l  blood);
and the females present in the “Puriﬁed males” (line DynGFP,
0.36% females; spanning cDNA densities equivalent to 0.24–24.3
female gametocytes/l  blood). The lower limit of quantiﬁcation,
i.e. the lowest tested dilution at which all replicates were reli-
ably quantiﬁed, was equivalent to 0.3 female gametocytes/l  blood
(“Puriﬁed females”, corresponding to 0.04 female gametocytes/PCR
reaction; Fig. 2A). PCR efﬁciency was 89.0% (se 1.6%) and not sig-
niﬁcantly different between the 4 tested samples (F3,175 = 1.48,
p = 0.22). Female gametocyte numbers and Cq values were sig-
niﬁcantly correlated (adjusted r2 = 0.97, p < 0.001), and the small
standard errors demonstrate high repeatability (Fig. 2A). Pfs25 RT-
qPCR efﬁciency (F1,11 = 1.96, p = 0.19) and Cq values (F1,12 = 0.68,
p = 0.42) were not affected by the presence of cDNA from “Asex-
ual parasites” (7.8 × 104 asexual parasites/l  blood) nor did these
vary across the percentage of parasites that were female game-
tocytes (0.0007–100%) or gametocyte densities (0.6–611 females
gametocytes/l  blood) similar to those found in natural P. falcip-
arum infections. This shows that the Pfs25 RT-qPCR is reliable and
sensitive for quantiﬁcation of female gametocytes, also in the pres-
ence large quantities of non-target nucleic acids, and therefore
neither gametocytaemia (proportion parasites that is gametocytes)
nor sex ratio (proportion of gametocytes that is male) affect the
accuracy with which female gametocytes are quantiﬁed.
For the male-speciﬁc PCR, gametocyte-speciﬁcity was con-
ﬁrmed by the absence of Pfs230p mRNA expression in the
P. falciparum “Asexual stages” sample (equivalent to 8.9 × 105
parasites/l  blood). The expression of Pfs230p mRNA is different for
gametocytes from the “Puriﬁed females”, the NF54, 3D7-1 and 3D7-
2 “Mixed sex gametocytes” (F3,119 = 67.21, p < 0.001), with Pfs230p
mRNA expression lowest in the “Puriﬁed females” (1.7 × 104 female
gametocytes/l blood) and highest in the samples with largest
proportion of males. When taking into account the presence of
2%, 5%, 5% and 20% male gametocytes in the samples of “Puri-
ﬁed females”, “3D7 Mixed sex gametocytes 3D7-1 and 3D7-2” and
“NF54 Mixed sex gametocytes”, respectively, the expression level
of Pfs230p mRNA per male gametocyte is not signiﬁcantly different
between the 4 samples (F3,119 = 1.40, p = 0.25, Fig. 2B). This con-
ﬁrms the previously published male-speciﬁcity of Pfs230p mRNA
expression [11].
The performance of the Pfs230p RT-qPCR assay was  further
assessed as described for the Pfs25 RT-qPCR, using 4 samples:
“Mixed sex gametocytes” clone 3D7, 2 samples each with 5%
males; spanning cDNA densities equivalent to 0.89–88.84 (3D7-
1) and 1.18–444.21 (3D7-2) male gametocytes/l  blood); “Mixed
sex gametocytes” sample NF54 (20% males; cDNA densities equiv-
alent to 0.2–200.2 male gametocytes/l  blood); and the males
present in the “Puriﬁed females” (line p47GFP, 2% males; span-
ning cDNA densities equivalent to 0.76–68.72 male gametocytes/l
blood). The lower limit of quantiﬁcation was equivalent to 1.8 male
gametocytes/l blood (“Mixed sex gametocytes” 3D7-1, corre-
sponding to 0.3 male gametocytes/PCR reaction; Fig. 2B). Detection
of Pfs230p mRNA was possible below 0.3 male gametocytes/PCR
reaction, but occasional false negatives occurred and quantiﬁca-
tion is unreliable due to a non-linear relationship between male
gametocyte densities and Cq values. Pfs230p RT-qPCR efﬁciency
was 92.0% (se 3.6%) and was not signiﬁcantly different for male
gametocytes from the 3D7-1, 3D7-2 and NF54 “Mixed sex game-
tocytes” and from the “Puriﬁed females” (F3,106 = 1.26, p = 0.29).
Above the lower limit of quantiﬁcation, male gametocyte num-
bers were signiﬁcantly correlated to Cq values and quantiﬁcation
was repeatable (adjusted r2 = 0.91, p < 0.001; Fig. 2B). Pfs230p RT-
qPCR efﬁciency (F1,22 = 0.0002, p = 0.99) and quantiﬁcation of male
gametocytes (F1,23 = 0.005, p = 0.94) were not affected by the
presence of cDNA from “Asexual parasites” (8.9 × 105 asexual
parasites/l  blood), the percentage of parasites that were male
gametocytes (0.002–100%) or the range of gametocyte densities
(1–324 male gametocytes/l  blood) similar to those found in nat-
ural infections. Because Pfs230p RT-qPCR was  not affected by large
quantities of non-target nucleic acids, the accuracy of male gameto-
cyte quantiﬁcation is not affected by gametocytaemia or sex ratio.
In conclusion, both sex-speciﬁc RT-qPCRs are accurate and more
sensitive than microscopy [5], and can quantify mature female and
male P. falciparum gametocytes, including submicroscopic game-
tocyte densities as low as 0.3 female and 1.8 male gametocytes/l
of blood. The female-speciﬁcity of the Pfs25 assay means that the
Pfs25 QT-NASBA, currently used for ﬁeld surveys, quantiﬁes female
gametocytes only [3]. Although this should be taken into account
when interpreting data, female density reﬂects an important aspect
of transmission because it places the upper limit on ookinete (off-
spring) numbers. The sex-speciﬁc RT-qPCRs facilitate the study of
why the densities of mature female and male gametocytes, and the
sex ratio (proportion of gametocytes that are male) vary during
infections and between hosts, and their inﬂuence on transmission.
Another application of the assays is the separate assessment of
female and male gametocyte clearance after drug treatment. Male
gametocytes are thought to be limiting for transmission in general
[2] and this could be exacerbated after treatment with gametocy-
tocidal drugs because males are more sensitive to a variety of drugs
compared to female gametocytes [7,18].
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